WolverHeme Happy Hour
En podcast af Bernard Marini, Anthony Perissinotti, et al.
35 Episoder
-
Dex and the Cytokine City: Managing CRS with Bispecifics
Udgivet: 7.4.2025 -
LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML
Udgivet: 11.3.2025 -
Episode 32: Navigating a BlinatumoMAD World
Udgivet: 21.1.2025 -
The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma
Udgivet: 15.1.2025 -
Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates
Udgivet: 24.12.2024 -
A Bunch of ASHholes Discuss Myeloma Abstracts
Udgivet: 16.11.2024 -
Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma
Udgivet: 8.11.2024 -
Episode 27: Mantle Cell Masterclass with Tycel Phillips
Udgivet: 10.10.2024 -
Houston, we don't have a problem... with APOLLO
Udgivet: 28.8.2024 -
From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment
Udgivet: 13.6.2024 -
Episode 24: Myeloma Madness with the Myeloma Man
Udgivet: 17.4.2024 -
Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion
Udgivet: 25.1.2024 -
LymphOMG: Pouring Over Lymphoma Abstracts from ASH
Udgivet: 29.12.2023 -
AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy
Udgivet: 19.12.2023 -
ASH Pregaming - Myeloma Madness with Manni and Papa Heme
Udgivet: 1.12.2023 -
AML Maintenance Part 2: a metaMORPHOsis?
Udgivet: 8.11.2023 -
AML Maintenance Part 1: Set Your QUAZARs to Stun
Udgivet: 25.10.2023 -
Episode 17: The Hemophilia Eras Tour
Udgivet: 23.8.2023 -
Common Sense Oncology: Outcomes That Matter
Udgivet: 1.8.2023 -
All too well: the reality of leukemia treatment
Udgivet: 8.6.2023
Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.